IN-VIVO BETA-CELL FUNCTION AT THE TRANSITION TO EARLY NON-INSULIN-DEPENDENT DIABETES-MELLITUS

被引:16
|
作者
SWINBURN, BA [1 ]
GIANCHANDANI, R [1 ]
SAAD, MF [1 ]
LILLIOJA, S [1 ]
机构
[1] NIDDKD,CLIN DIABET & NUTR SECT,PHOENIX,AZ 85016
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 06期
关键词
D O I
10.1016/0026-0495(95)90189-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired insulin secretion occurs at some stage in the development of non-insulin dependent diabetes mellitus (NIDDM), possibly during impaired glucose tolerance (IGT) or early NIDDM. To assess insulin secretion at these critical stages, we measured the first-phase insulin response (to glucose and arginine), maximal secretory capacity, and glucose potentiation slope for insulin secretion in Pima Indians with normal glucose tolerance (n = 20), IGT (n = 9), and mild (fasting glucose < 7.8 mmol/L) NIDDM (n = 7). We also measured oral glucose tolerance and insulin action. Subjects with IGT were more insulin-resistant (P < .05) than normals. A wide range of insulin secretion was noted, although as a group, no significant impairment was detected. Subjects with mild NIDDM were similarly insulin-resistant, but they also had impaired insulin secretion. The first-phase response to glucose was markedly reduced in absolute terms (P < .001), but all secretion indices were impaired relative to the degree of insulin resistance (P = .05 to P < .0001). These results suggest that in Pima Indians, impairment of insulin secretion, especially the first-phase response to glucose, is associated with mild NIDDM. Insulin secretion in IGT is variable and, overall, seems intact, although a subtle defect in the first-phase insulin response to glucose could not be ruled out in this study. Glucose sensing for first-phase secretion may be one of the early secretory defects in the progression of glucose intolerance and seems to be critical at the transition from IGT to early NIDDM. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:757 / 764
页数:8
相关论文
共 50 条
  • [31] DIABETES GENES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    LEAHY, JL
    BOYD, AE
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (01): : 56 - 57
  • [32] THE GENETICS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    PILLAY, TS
    LANGLOIS, WJ
    OLEFSKY, JM
    ADVANCES IN GENETICS, VOL 32: INCORPORATING MOLECULAR GENETIC MEDICINE, 1995, 32 : 51 - 98
  • [33] HYPERINSULINEMIA AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    MAHLER, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02): : 110 - 111
  • [34] STRATEGIES FOR NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    RIDDLE, MC
    HOSPITAL PRACTICE, 1993, 28 (4A): : 14 - &
  • [35] MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    KUMAR, S
    DIABETIC MEDICINE, 1995, 12 (08) : 647 - 648
  • [36] WHICH COMES FIRST IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - INSULIN-RESISTANCE OR BETA-CELL FAILURE - BOTH COME FIRST
    WEIR, GC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (23): : 1878 - 1879
  • [37] THERAPEUTIC EFFECT OF TOLBUTAMIDE IN NON-INSULIN DEPENDENT DIABETES-MELLITUS (NIDDM) - RELATION TO BETA-CELL FUNCTION
    DAMSGAARD, EM
    FABER, O
    FROLAND, A
    IVERSEN, S
    ACTA ENDOCRINOLOGICA, 1982, 100 (03): : 416 - 420
  • [38] SPLIT PROINSULIN IS AN EARLY MARKER OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    BERNE, C
    LITHELL, H
    CLARK, PMS
    HALES, CN
    DIABETOLOGIA, 1994, 37 : A57 - A57
  • [39] NON-INSULIN-DEPENDENT DIABETES-MELLITUS WITH EARLY ONSET IN BLACKS AND INDIANS
    ASMAL, AC
    DAYAL, B
    JIALAL, I
    LEARY, WP
    OMAR, MAK
    PILLAY, NL
    THANDROYEN, FT
    SOUTH AFRICAN MEDICAL JOURNAL, 1981, 60 (03): : 93 - 96
  • [40] EARLY PHARMACOTHERAPY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - HELP OR HINDRANCE
    SHEEHAN, JP
    ULCHAKER, MM
    ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) : 198 - &